Studies show that antidepressants don’t always work. One psychologist explains how to take control of negative thoughts ...
Patients who received the drug, called navacaprant, showed no more improvement in depressive symptoms than people who ...
Key Takeaways Neumora Therapeutics reported its experimental depression drug didn't meet expectations, and shares plunged.The ...
Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...
The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results ...
In zebrafish, ketamine causes changes a brain circuit involved in "giving up." That may help explain how the drug helps ...
To treat depression, the tech magnate has said he'd rather use ketamine, a dissociative anesthetic, than traditional antidepressants.
Neumora Therapeutics, Inc. (NASDAQ:NMRA) stock traded lower after the company released data from the Phase 3 KOASTAL-1 Study ...
Jan 2 (Reuters) - Neumora Therapeutics' (NMRA.O), opens new tab shares tumbled more than 80% on Thursday after its experimental depression drug failed to reduce symptoms such as sadness and ...
Anxiety or depression can cause a great deal of emotional pain. Unfortunately, many people choose to self-medicate with ...